Geron Corp (GERN) concluded trading on Wednesday at a closing price of $2.99, with 5.67 million shares of worth about $16.95 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -36.11% during that period and on January 22, 2025 the price saw a gain of about 1.01%. Currently the company’s common shares owned by public are about 603.10M shares, out of which, 564.66M shares are available for trading.
Stock saw a price change of 1.70% in past 5 days and over the past one month there was a price change of -20.69%. Year-to-date (YTD), GERN shares are showing a performance of -15.54% which increased to 59.04% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $1.64 but also hit the highest price of $5.34 during that period. The average intraday trading volume for Geron Corp shares is 10.37 million. The stock is currently trading -8.06% below its 20-day simple moving average (SMA20), while that difference is down -18.67% for SMA50 and it goes to -27.15% lower than SMA200.
Geron Corp (NASDAQ: GERN) currently have 603.10M outstanding shares and institutions hold larger chunk of about 78.47% of that.
The stock has a current market capitalization of $1.81B and its 3Y-monthly beta is at 0.52. It has posted earnings per share of -$0.32 in the same period. It has Quick Ratio of 2.74 while making debt-to-equity ratio of 0.30. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for GERN, volatility over the week remained 4.19% while standing at 5.12% over the month.
Analysts are in expectations that Geron Corp (GERN) stock would likely to be making an EPS of -0.05 in the current quarter, while forecast for next quarter EPS is -0.04 and it is -0.07 for next year. For the current quarter EPS, analysts have given the company a lowest target -0.06 which is -0.03 at the higher side of the target for the same. When we compare those targets with actual EPS, we find that company posted an EPS of -0.09 in the same quarter a year ago. Stock’s fiscal year EPS is expected to rise by 19.11% while it is estimated to increase by 70.82% in next year.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by H.C. Wainwright on November 05, 2024 offering a Buy rating for the stock and assigned a target price of $8 to it. On September 09, 2024, Leerink Partners Initiated their recommendations, while on April 30, 2024, Robert W. Baird Downgrade their ratings for the stock with a price target of $4.50. Stock get a Buy rating from TD Cowen on April 29, 2024.
